ProPhase Labs, Inc. — Director's Dealing 2020

Aug 17, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ProPhase Labs, Inc. (PRPH)
CIK: 0000868278
Period of Report: 2020-08-13

Reporting Person: GLECKEL LOUIS MD (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-08-13	Common Stock, par value $0.0005	P	50000	$2.75	Acquired	273840	Direct

Footnotes

F1: These shares were purchased in a private transaction from Ted Karkus, Chairman and Chief Executive Officer of the Issuer, pursuant to the terms of a Stock Purchase Agreement